Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B (LB80380)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
LG Life Sciences Identifier:
First received: November 12, 2010
Last updated: April 13, 2012
Last verified: April 2012